Total Payments
$27,075
2024 Payments
$1,845
Companies
8
Transactions
17
Medicare Patients
2,209
Medicare Billing
$78,720
Payment Breakdown by Category
Consulting$18,953 (70.0%)
Other$7,160 (26.4%)
Travel$878.22 (3.2%)
Food & Beverage$84.39 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $18,953 | 7 | 70.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,200 | 3 | 15.5% |
| Honoraria | $2,660 | 1 | 9.8% |
| Travel and Lodging | $878.22 | 2 | 3.2% |
| Compensation for serving as faculty or as a speaker for a medical education program | $300.00 | 1 | 1.1% |
| Food and Beverage | $84.39 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $14,925 | 5 | $0 (2018) |
| Cepheid | $5,378 | 6 | $0 (2021) |
| Life Technologies Corporation | $2,660 | 1 | $0 (2023) |
| Roche Diagnostics Corporation | $2,183 | 1 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $1,845 | 1 | $0 (2024) |
| Stemline Therapeutics Inc. | $41.07 | 1 | $0 (2019) |
| Seattle Genetics, Inc. | $33.14 | 1 | $0 (2019) |
| Takeda Pharmaceuticals America, Inc. | $10.18 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,845 | 1 | Bayer Healthcare Pharmaceuticals Inc. ($1,845) |
| 2023 | $4,843 | 2 | Life Technologies Corporation ($2,660) |
| 2021 | $300.00 | 1 | Cepheid ($300.00) |
| 2020 | $1,200 | 2 | Cepheid ($1,200) |
| 2019 | $3,952 | 5 | Cepheid ($3,878) |
| 2018 | $14,925 | 5 | CSL Behring ($14,925) |
| 2017 | $10.18 | 1 | Takeda Pharmaceuticals America, Inc. ($10.18) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Vitrakvi (Drug) | Consulting Fee | Cash or cash equivalent | $1,845.00 | General |
| Category: Oncology | ||||||
| 11/30/2023 | Life Technologies Corporation | — | Honoraria | Cash or cash equivalent | $2,659.52 | General |
| 06/06/2023 | Roche Diagnostics Corporation | — | Consulting Fee | Cash or cash equivalent | $2,183.00 | General |
| Category: None | ||||||
| 08/10/2021 | Cepheid | GENEXPERT (Device) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $300.00 | General |
| Category: Devices | ||||||
| 11/03/2020 | Cepheid | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| 08/05/2020 | Cepheid | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| 11/06/2019 | Cepheid | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| 11/06/2019 | Cepheid | — | Travel and Lodging | In-kind items and services | $536.00 | General |
| 11/06/2019 | Cepheid | — | Travel and Lodging | In-kind items and services | $342.22 | General |
| 09/13/2019 | Seattle Genetics, Inc. | — | Food and Beverage | In-kind items and services | $33.14 | General |
| 09/12/2019 | Stemline Therapeutics Inc. | ELZONRIS (Drug) | Food and Beverage | In-kind items and services | $41.07 | General |
| Category: ONCOLOGY | ||||||
| 07/21/2018 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $1,350.00 | General |
| 06/11/2018 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $3,600.00 | General |
| 05/22/2018 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $2,850.00 | General |
| 05/09/2018 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $3,750.00 | General |
| 04/26/2018 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $3,375.00 | General |
| 03/20/2017 | Takeda Pharmaceuticals America, Inc. | Uloric (Drug) | Food and Beverage | In-kind items and services | $10.18 | General |
| Category: Gout/Rheumatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 961 | 1,083 | $143,316 | $22,973 |
| 2022 | 4 | 351 | 562 | $127,086 | $16,867 |
| 2021 | 7 | 408 | 676 | $142,508 | $22,003 |
| 2020 | 10 | 489 | 902 | $170,398 | $16,878 |
Total Patients
2,209
Total Services
3,223
Medicare Billing
$78,720
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0452 | Molecular pathology procedure; physician interpretation and report | Facility | 2023 | 335 | 409 | $72,815 | $13,660 | 18.8% |
| 84165 | Protein measurement, serum | Facility | 2023 | 321 | 353 | $27,847 | $4,610 | 16.6% |
| 86334 | Immunologic analysis technique on serum (immunofixation) | Facility | 2023 | 180 | 189 | $25,726 | $2,491 | 9.7% |
| 84166 | Protein measurement, body fluid | Facility | 2023 | 68 | 74 | $8,518 | $1,238 | 14.5% |
| 86335 | Immunologic analysis technique on body fluid, other fluids with concentration | Facility | 2023 | 57 | 58 | $8,410 | $973.86 | 11.6% |
| G0452 | Molecular pathology procedure; physician interpretation and report | Facility | 2022 | 294 | 373 | $63,410 | $12,306 | 19.4% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 11 | 134 | $49,458 | $2,903 | 5.9% |
| G0452 | Molecular pathology procedure; physician interpretation and report | Office | 2022 | 24 | 30 | $5,100 | $961.20 | 18.8% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 11 | 13 | $5,266 | $348.61 | 6.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 11 | 12 | $3,852 | $347.55 | 9.0% |
| G0452 | Molecular pathology procedure; physician interpretation and report | Facility | 2021 | 317 | 510 | $86,020 | $17,094 | 19.9% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2021 | 14 | 89 | $21,762 | $1,996 | 9.2% |
| 88189 | Flow cytometry technique for dna or cell analysis, 16 or more markers | Facility | 2021 | 21 | 21 | $24,249 | $1,340 | 5.5% |
| 85097 | Bone marrow, smear interpretation | Facility | 2021 | 13 | 13 | $2,761 | $500.37 | 18.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2021 | 14 | 14 | $2,940 | $413.98 | 14.1% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2021 | 14 | 14 | $2,918 | $387.10 | 13.3% |
| 85060 | Blood smear interpretation by physician with written report | Facility | 2021 | 15 | 15 | $1,858 | $270.48 | 14.6% |
| G0452 | Molecular pathology procedure; physician interpretation and report | Facility | 2020 | 335 | 583 | $90,212 | $8,277 | 9.2% |
| 88341 | Special stained specimen slides to examine tissue | Facility | 2020 | 21 | 181 | $33,372 | $4,166 | 12.5% |
| 88189 | Flow cytometry technique for dna or cell analysis | Facility | 2020 | 23 | 23 | $26,358 | $1,595 | 6.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2020 | 20 | 20 | $3,560 | $613.48 | 17.2% |
| 88342 | Tissue or cell analysis by immunologic technique | Facility | 2020 | 21 | 21 | $2,920 | $601.63 | 20.6% |
| 88365 | Analysis of genetic material | Facility | 2020 | 14 | 14 | $6,938 | $499.98 | 7.2% |
| 85097 | Bone marrow, smear interpretation | Facility | 2020 | 12 | 12 | $2,740 | $478.72 | 17.5% |
| 85060 | Blood smear interpretation by physician with written report | Facility | 2020 | 19 | 19 | $2,173 | $357.54 | 16.5% |
About Dr. Yi Ding, MD
Dr. Yi Ding, MD is a Hematology healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2010. The National Provider Identifier (NPI) number assigned to this provider is 1679884274.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yi Ding, MD has received a total of $27,075 in payments from pharmaceutical and medical device companies, with $1,845 received in 2024. These payments were reported across 17 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($18,953).
As a Medicare-enrolled provider, Ding has provided services to 2,209 Medicare beneficiaries, totaling 3,223 services with total Medicare billing of $78,720. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Other Specialties Molecular Genetic Pathology, Anatomic Pathology & Clinical Pathology
- Location Rochester, NY
- Active Since 06/29/2010
- Last Updated 10/05/2017
- Taxonomy Code 207ZH0000X
- Entity Type Individual
- NPI Number 1679884274
Products in Payments
- Vitrakvi (Drug) $1,845
- GENEXPERT (Device) $300.00
- ELZONRIS (Drug) $41.07
- Uloric (Drug) $10.18
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Rochester
Angela Dispenzieri, M.d, M.D
Hematology — Payments: $371,763
Hematology $371,763
Stephen Ansell, M.d, M.D
Hematology — Payments: $297,187
Hematology $297,187
Morie Gertz, M.d, M.D
Hematology — Payments: $285,858
Hematology $285,858
Dr. Adrienne Victor, M.d, M.D
Hematology — Payments: $143,778
Hematology $143,778
Thomas Witzig, M.d, M.D
Hematology — Payments: $110,341
Hematology $110,341
Dr. Brea Lipe, M.d, M.D
Hematology — Payments: $87,225
Hematology $87,225